A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 14,025 shares of EXAS stock, worth $806,157. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,025
Previous 14,071 0.33%
Holding current value
$806,157
Previous $594,000 60.61%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$42.43 - $70.83 $1,951 - $3,258
-46 Reduced 0.33%
14,025 $954,000
Q2 2024

Jul 30, 2024

SELL
$41.33 - $74.26 $41 - $74
-1 Reduced 0.01%
14,071 $594,000
Q3 2023

Oct 30, 2023

SELL
$65.94 - $99.04 $2,571 - $3,862
-39 Reduced 0.28%
14,072 $959,000
Q2 2023

Aug 04, 2023

SELL
$62.68 - $95.05 $1,755 - $2,661
-28 Reduced 0.2%
14,111 $1.33 Million
Q1 2023

May 02, 2023

BUY
$47.19 - $70.77 $179,274 - $268,855
3,799 Added 36.74%
14,139 $958,000
Q3 2022

Oct 19, 2022

BUY
$31.97 - $49.37 $3,548 - $5,480
111 Added 1.09%
10,340 $336,000
Q2 2022

Jul 13, 2022

BUY
$35.61 - $76.23 $47,824 - $102,376
1,343 Added 15.11%
10,229 $403,000
Q1 2022

Apr 19, 2022

SELL
$57.56 - $82.54 $5,410 - $7,758
-94 Reduced 1.05%
8,886 $621,000
Q3 2021

Oct 15, 2021

SELL
$90.24 - $124.05 $5,594 - $7,691
-62 Reduced 0.69%
8,980 $857,000
Q4 2020

Feb 02, 2021

BUY
$99.61 - $142.12 $4,980 - $7,106
50 Added 0.56%
9,042 $1.2 Million
Q2 2020

Aug 12, 2020

BUY
$55.75 - $92.75 $89,423 - $148,771
1,604 Added 21.71%
8,992 $781,000
Q1 2020

Apr 21, 2020

SELL
$37.9 - $104.44 $57,039 - $157,182
-1,505 Reduced 16.92%
7,388 $428,000
Q4 2019

Jan 24, 2020

BUY
$77.66 - $99.74 $148,718 - $191,002
1,915 Added 27.44%
8,893 $822,000
Q3 2019

Oct 16, 2019

BUY
$90.37 - $122.49 $102,389 - $138,781
1,133 Added 19.38%
6,978 $630,000
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $523,185 - $689,943
5,845 New
5,845 $689,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.